EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study

Miriam Olivola, Filippo Mazzoni, Barbara Tarantino, Alessandro Guffanti, Matteo Marcatili, Federico Luigi Motta, Ranieri Domenico Cornaggia, Vassilis Martiadis, Tiziano Prodi, Pierluigi Politi, Natascia Brondino, Giovanni Martinotti und 2 weitere

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2025.120231 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Miriam Olivola und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy; Department of Mental Health and Addiction Services, ASST Fateb…. Hauptthemen laut MEDLINE: Ketamine, Depressive Disorder, Treatment-Resistant, Antidepressive Agents, Theory of Mind. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Treatment-Resistant Depression (TRD) remains a major challenge in the management of Major Depressive Disorder (MDD). Esketamine, the S-enantiomer of ketamine and a glutamatergic modulator, has been approved by the FDA and EMA for TRD in 2019. Beyond its rapid antidepressant effects, esketamine may enhance neuroplasticity, facilitating the reconnection with emotional and cognitive processes, improving mentalization, social cognition and promoting resilience. OBJECTIVE: This prospective multicenter observational study aimed to evaluate esketamine's therapeutic impact on depressive symptoms and explore whether psychological and clinical factors-including mentalization, psychache, social cognition, suicidality, and cognitive-emotional rigidity-could predict treatment response, enabling a more personalized approach to TRD management. METHODS: Thirty-six TRD patients treated with esketamine were assessed over a six-month follow-up period using psychometric measures of depression severity, suicidality, mentalization, social cognition, psychache, and cognitive-emotional rigidity. RESULTS: A significant association emerged between mentalization deficits and depressive symptoms. Specifically, patients with poor baseline mentalization abilities exhibited higher Montgomery-Åsberg Depression Rating Scale (MADRS) scores both at baseline and throughout follow-up. In contrast, greater cognitive rigidity appeared to have a protective role, potentially mitigating negative thinking and providing emotional stability, which may enhance resilience to stressors. CONCLUSIONS: These findings highlight the importance of a personalized treatment approach in TRD. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals with TRD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineDepressive Disorder, Treatment-ResistantAntidepressive AgentsTheory of MindMajor Depressive DisorderEmotionsCognitionHumansMaleFemaleProspective StudiesMiddle AgedAdultTreatment OutcomeSocial Cognition

Stichwörter der Autor:innen

Cognitive rigidityEsketamineMajor Depressive DisorderMentalizationPsychacheTreatment-Resistant Depression

Substanzen

KetamineEsketamineAntidepressive Agents

Autor:innen und Institutionen

  • Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy; Department of Mental Health and Addiction Services, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Department of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, Italy.
  • Department of Mental Health, Fondazione IRCSS San Gerardo dei Tintori, Monza, Italy.
  • School of Medicine and Surgery, University of Milano-Bicocca, Italy.
  • ASL Napoli 1 Centro, Department of Mental Health, Napoli, Italy.
  • Department of Mental Health, Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy. Electronic address: tiziano.prodi@unimi.it.

Zitieren

APA

Olivola, M., Mazzoni, F., Tarantino, B., Guffanti, A., Marcatili, M., Motta, F. L., Cornaggia, R. D., Martiadis, V., Prodi, T., Politi, P., Brondino, N., Martinotti, G., Clerici, M., & Dell'Osso, B. (2026). Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120231

Vancouver

Olivola M, Mazzoni F, Tarantino B, Guffanti A, Marcatili M, Motta FL, et al. Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120231

BibTeX
@article{Olivola2026,
  author = {Olivola, Miriam and Mazzoni, Filippo and Tarantino, Barbara and Guffanti, Alessandro and Marcatili, Matteo and Motta, Federico Luigi and Cornaggia, Ranieri Domenico and Martiadis, Vassilis and Prodi, Tiziano and Politi, Pierluigi and Brondino, Natascia and Martinotti, Giovanni and Clerici, Massimo and Dell'Osso, Bernardo},
  title = {Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2025.120231}
}
Kostenlos starten →